Digital Pathology & Histology - Novel liquid biopsy technology could advance cancer diagnostics and monitoring
View as a Web Page
News Medical
 
  Digital Pathology & Histology Digital Pathology & Histology logo  
  The latest digital pathology & histology news from AZoNetwork  
 

Digital pathology and the PathoVerse: A conversation with Dr. SinghDigital pathology and the PathoVerse: A conversation with Dr. Singh

In this interview, industry expert Dr. Raj Singh discusses the PathoVerse, a pioneering global digital ecosystem designed to transform pathology through connectivity, AI integration, and collaborative innovation across research and clinical practice.

Read the Interview
 
   Novel liquid biopsy technology could advance cancer diagnostics and monitoringNovel liquid biopsy technology could advance cancer diagnostics and monitoring
 
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow.
 
   New federal guidelines shift cervical cancer screening to HPV testingNew federal guidelines shift cervical cancer screening to HPV testing
 
New cervical cancer screening guidelines emphasize self-collection and hrHPV testing, aiming to increase screening rates and improve women's health outcomes.
 
 Skipping sentinel lymph node biopsy may be safe for some early-stage breast cancer patients
 
Skipping sentinel lymph node biopsy may be safe for some early-stage breast cancer patientsSkipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or survival after a median five years of follow-up, according to results from the BOOG 2013-08 phase III clinical trial, presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.
 
 
 New technique helps understand how bacterial shapes contribute to disease
 
New technique helps understand how bacterial shapes contribute to diseaseScientists have long known that bacteria come in many shapes and sizes, but understanding what those differences mean has remained a major challenge, especially for species that can't be grown in the lab. Now, a new study led by Nina Wale, an Assistant Professor in MSU's Department of Microbiology, Genetics, & Immunology, introduces a groundbreaking method that could change how researchers study bacterial diversity.
 
 
 Brazilian study shows liquid biopsies can expedite lung cancer care
 
Brazilian study shows liquid biopsies can expedite lung cancer careIn Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.
 
 
 Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutations
 
Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutationsLiquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA circulating in the blood.
 
 
 New Label-Free Breakthrough for Studying Bacterial Shape Diversity
 
New Label-Free Breakthrough for Studying Bacterial Shape DiversityScientists have long known that bacteria come in many shapes and sizes, but understanding what those differences mean has remained a major challenge, especially for species that can't be grown in the lab.
 
 
 AI model improves recurrence risk stratification in HR-positive, HER2-negative breast cancer
 
AI model improves recurrence risk stratification in HR-positive, HER2-negative breast cancerAn artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, HER2-negative breast cancer, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.
 
 
 New findings show why the human intestine uniquely presents gluten to T cells
 
New findings show why the human intestine uniquely presents gluten to T cellsHuman intestinal M cells function as dendritic cell-like antigen-presenting cells, displaying constitutive MHC-II activity and specialized machinery for processing gluten. Their ability to deamidate and present gliadin peptides positions them as key initiators of immune responses relevant to coeliac disease.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026